---
layout: default
title: Analysis Portfolio
permalink: /analysis/
---

# Investment Analysis Portfolio

Comprehensive business analyses following Charlie Munger's investment framework. Each analysis includes business model evaluation, competitive positioning, financial assessment, risk analysis, and valuation.

## Analysis Framework

Every analysis follows this systematic approach:

1. **Circle of Competence Check** - Can we understand this business?
2. **Business Model Analysis** - How does it make money?
3. **Competitive Moat Assessment** - What protects profits?
4. **Financial Health Review** - Balance sheet and cash flows
5. **Management Evaluation** - Capital allocation and integrity
6. **Risk Analysis** - What could go wrong?
7. **Valuation Assessment** - Price vs intrinsic value
8. **Investment Decision** - Buy/sell/hold with conviction level

---

## Analysis Portfolio

### Technology & Software

<div class="analysis-grid">
  <a href="BABA_analysis_20250921.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">BABA</span>
      <span class="analysis-recommendation hold">CAUTIOUS</span>
    </div>
    <h3>Alibaba - Chinese E-commerce Platform</h3>
    <p class="analysis-insight">Strong business fundamentals but significant regulatory and competitive risks</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 21, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="FIG_analysis_20250920.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">FIG</span>
      <span class="analysis-recommendation hold">CAUTIOUS</span>
    </div>
    <h3>Figma - Design Software Platform</h3>
    <p class="analysis-insight">Dominant market position but extreme valuation at 32.6x EV/Revenue</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 20, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="RKLB_business_explanation_20250921.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">RKLB</span>
      <span class="analysis-recommendation hold">WATCH</span>
    </div>
    <h3>Rocket Lab - Aerospace & Launch</h3>
    <p class="analysis-insight">#2 U.S. space launch provider with strong positioning but high valuation</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 21, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>
</div>

### Consumer & Retail

<div class="analysis-grid">
  <a href="wwqi/analysis/COST_analysis_20250921.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">COST</span>
      <span class="analysis-recommendation hold">HOLD</span>
    </div>
    <h3>Costco - Warehouse Club Retail</h3>
    <p class="analysis-insight">Exceptional business model with membership moats, but 54x P/E lacks margin of safety</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 21, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="LULU_analysis_20250920.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">LULU</span>
      <span class="analysis-recommendation buy">WEAK BUY</span>
    </div>
    <h3>Lululemon - Athletic Apparel</h3>
    <p class="analysis-insight">Temporary headwinds creating opportunity for quality brand with 40-70% upside potential</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 20, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>
</div>

### Consumer Staples & Transportation

<div class="analysis-grid">
  <a href="KO_analysis_20250920.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">KO</span>
      <span class="analysis-recommendation buy">QUAL. BUY</span>
    </div>
    <h3>Coca-Cola - Global Beverages</h3>
    <p class="analysis-insight">Classic Munger investment with durable moats, predictable cash flows, and reasonable valuation</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 20, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="UBER_analysis_20250921.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">UBER</span>
      <span class="analysis-recommendation hold">HOLD</span>
    </div>
    <h3>Uber - Platform Mobility</h3>
    <p class="analysis-insight">Successful transformation to profitability but limited margin of safety at current valuation</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 21, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>
</div>

### Healthcare & Pharmaceuticals

<div class="analysis-grid">
  <a href="LLY_analysis_20250924.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">LLY</span>
      <span class="analysis-recommendation hold">HOLD/WAIT</span>
    </div>
    <h3>Eli Lilly - Diabetes & Obesity Pharmaceuticals</h3>
    <p class="analysis-insight">Exceptional GLP-1 franchise with dominant market position but trading at 47-61% premium to fair value</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 24, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="NVO_analysis_20250924.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">NVO</span>
      <span class="analysis-recommendation buy">BUY</span>
    </div>
    <h3>Novo Nordisk - Diabetes & Obesity Care</h3>
    <p class="analysis-insight">Dominant GLP-1 franchise trading at 35-52% discount to intrinsic value following competitive concerns</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 24, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>

  <a href="BDMS_analysis_20250924.html" class="analysis-card">
    <div class="analysis-header">
      <span class="analysis-ticker">BDMS</span>
      <span class="analysis-recommendation buy">WEAK BUY</span>
    </div>
    <h3>Bangkok Dusit Medical - Thai Healthcare</h3>
    <p class="analysis-insight">Leading Southeast Asian healthcare provider with attractive valuation despite regional risks</p>
    <div class="analysis-meta">
      <span class="analysis-date">Sep 24, 2025</span>
      <span class="analysis-status">ðŸ“Š View Analysis</span>
    </div>
  </a>
</div>

---

## Analysis Statistics

### By Recommendation
- **Buy:** 3 (33%)
- **Hold:** 6 (67%) 
- **Sell:** 0 (0%)

### By Sector
- **Technology:** 3 analyses
- **Consumer Discretionary:** 2 analyses  
- **Consumer Staples:** 1 analysis
- **Transportation:** 1 analysis
- **Healthcare:** 3 analyses

### Key Insights
- Most quality businesses currently trade at full/high valuations
- Limited opportunities with adequate margin of safety
- Patience required for better entry points
- Focus on business quality over current price action

---

## Analysis Quality Metrics

**Research Standards:**
- âœ… Primary source verification (10-K, earnings calls)
- âœ… Disconfirming evidence actively sought
- âœ… Multiple valuation scenarios analyzed  
- âœ… Margin of safety calculations
- âœ… Opportunity cost assessments

**Average Analysis Time:** 12-18 hours per company  
**Follow-up Cadence:** Quarterly earnings review, annual deep dive

---

*All analyses follow the same rigorous framework to ensure consistency and quality. Recommendations reflect margin of safety principles rather than short-term price movements.*